| Date | Hs Code | Spanish Product Description | English Product Description | Quantity | Measure Unit | Peru Importer Name | Foreign Exporter Name | Origin Country | Details |
|---|---|---|---|---|---|---|---|---|---|
| 04-01-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 1G CICLOFOSFAMIDA 1G / L:01690 / VTO: 12/2020 / EN CAJA DE CARTON X 1 VIAL S/M S/M | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 1G 1G / L: 01690 / VTO: 12/2020 / EN CARTON X 1 VIAL S / M S / M | 36 | KG | PERULAB SA |  | ARGENTINA | |
| 30-01-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, S/M, S/M MEDICAMENTO ONCOLOGICO DE USO HUMANO. LOTE: E615811 VENCE: 17/12/2021 CYCLOPHOSPHAMIDE 1G INJ. (10V/BOX) POLVO PARA SOLUCION INYECTABLE R.D. N¦ 279-2019-DIGEMID/DPF/UFM/MINSA. | MEDICINAL PRODUCTS FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, S / M, S / M MEDICINAL ONCOLOGICO FOR HUMAN USE. LOT: E615811 EXPIRES: 12/17/2021 CYCLOPHOSPHAMIDE INJ 1G. (10V / BOX) POWDER FOR INJECTION R.D. N| 279-2019-DIGEMID / DPF / UFM / MINSA. | 119 | KG | PALMAGYAR S.A. | KO******INC | KOREA, REPUBLIC OF | |
| 15-02-2019 | 3822009000 | Reactivos De Diagnostico O De Laboratorio Sobre Cualquier Soporte Y Reactivos De Diagnostico O De Laboratorio Preparados, Incluso Sobre Soporte, Excepto Los De Las Partidas 30.02 O 30.06 ESTANDAR DE REFERENCIA, S/M, S/M CAJA ESTANDAR (CICLOFOSFAMIDA) LOTE: 20180503. VENCE: 04/2020 | DIAGNOSTIC REAGENTS OR LABORATORY BACKING AND REAGENTS DIAGNOSTIC OR LABORATORY PREPARATIONS, EVEN ON A BACKING, OTHER THAN THOSE OF HEADING 3002 OR 3006 REFERENCE STANDARD, S / M, S / M CASE (CYCLOPHOSPHAMIDE) LOT: 20180503. EXPIRES: 04/2020 | 0.004 | KG | GP PHARM S.A. | G ****** SA | ARGENTINA | |
| 18-02-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, LKM, S/M CODIGO 23011, LOTE: I817A , VENC. 31/12/2020 MEDICAMENTO PARA HUMANO CICLOFOSFAMIDA 1GR X 1 FA_PE / CICLOFOSFAMIDA 1000MG PL X 1 F_PE EXP 17-038372-1 DE FECHA 04.05.2017 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, LKM, S / M CODE 23011, LOT: I817A, VENC. 31/12/2020 FOR HUMAN CICLOFOSFAMIDA 1GR MEDICINAL X 1 FA_PE / CICLOFOSFAMIDA 1000MG PL X 1 F_PE 17-038372-1 EXP DATE 05/04/2017 | 88.97 | KG | LKM PERU S.A. | LA******A.. | ARGENTINA | |
| 01-03-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, LKM, S/M CODIGO 23011, LOTE: I818A , VENCE: 31/01/2021 MEDICAMENTO PARA HUMANO CICLOFOSFAMIDA 1000 MG EXP 17-038372-1 DE FECHA 04.05.2017 | MEDICINAL PRODUCTS FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, LKM, S / M CODE 23011 LOT: I818A OVERCOME: 31/01/2021 1000 CICLOFOSFAMIDA MEDICINAL PRODUCT FOR HUMAN 17-038372-1 MG EXP DATE 04/05/2017 | 236.68 | KG | LKM PERU S.A. | LA******.A. | ARGENTINA | |
| 07-03-2019 | 2934999000 | Demas Acidos Nucleicos Y Sus Sales, Aunque No Sean De Constitucion Quimica Definida; Los Demas Compuestos Heterociclicos. CYCLOPHOSPHAMIDE, SIGMA ALDRICH, S/M PHR1404, BATCH: LRAB3626 REACTIVOS PARA LABORATORIOS,SINTESIS DE SUSTANCIAS , 1 X 1G CYCLOPHOSPHAMIDE | DEMAS NUCLEIC ACIDS AND THEIR SALTS, SEAN NOT CHEMICALLY DEFINED; OTHER HETEROCYCLIC COMPOUNDS. CYCLOPHOSPHAMIDE, SIGMA ALDRICH, S / M PHR1404, BATCH: LRAB3626 LABORATORY REAGENTS, SYNTHESIS OF SUBSTANCES, 1 X 1G CYCLOPHOSPHAMIDE | 0.001 | KG | MERCK PERUANA S A | SI******LLC | UNITED STATES | |
| 13-03-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, S/M, S/M EN CAJA DE CARTON FOLDCOTE X 1, 5, 10, 50 Y 100 VIALES DE VIDRIO TIPO I INCOLORO LOTE: E615901 VENC: 10/01/2022 CYCLOPHOSPHAMIDE 1G INJ. POLVO PARA SOLUCIONES INYECTABLES R.D. N? 279-2019-DIGEMID/DPF/UFM/MINSA | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, S / M S / M IN CARTON FOLDCOTE X 1, 5, 10, 50 AND 100 VIALS OF GLASS TYPE I COLORLESS LOT: VENC E615901: 01/10/2022 CYCLOPHOSPHAMIDE INJ 1G. POWDER FOR INJECTION SOLUTIONS R.D. N? 279-2019-DIGEMID / DPF / UFM / MOH | 112.5 | KG | PALMAGYAR S.A. | KO******INC | KOREA, REPUBLIC OF | |
| 18-03-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CYCLOPHOSPHAMIDE, S/M, S/M LOTE N? RO190212T FAB: 02-2019 VENCE: 01-2021 CICLOFOSFAMIDA 50 MG TABLETA RECUBIERTA, CYCLOPHOSPHAMIDE TABLETS USP 50 MG LEY N? 27450, LEY QUE EXONERA DE PAGO DE IGV Y DERECHOS ARANCELARIOS | MEDICINAL PRODUCTS FOR HUMAN USE, FOR HIV CYCLOPHOSPHAMIDE TREATMENT ONCOLOGICO O, S / M, S / M LOT N? RO190212T FAB: 02-2019 EXPIRES: 01-2021 CICLOFOSFAMIDA 50 MG TABLET COATED, CYCLOPHOSPHAMIDE 50 MG TABLETS USP LAW N? 27450, ACT EXONERATING IGV PAYMENT AND CUSTOMS DUTIES | 44.05 | KG | CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD | VE******LTD | INDIA | |
| 10-04-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 1G CICLOFOSFAMIDA 1G / L:01835 / VTO: 03/2021 / EN CAJA DE CARTON X 1 VIAL S/M S/M | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 1G 1G / L: 01835 / VTO: 03/2021 / EN CARTON X 1 VIAL S / M S / M | 51.53 | KG | PERULAB SA | LA******S.A | ARGENTINA | |
| 30-04-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, LKM, S/M CODIGO 23011, LOTE: I576A , VENCE: 31/07/2020 MEDICAMENTO PARA HUMANO CICLOFOSFAMIDA 1000 MG EXP 17-038372-1 DE FECHA 04.05.2017 | MEDICINAL PRODUCTS FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, LKM, S / M CODE 23011 LOT: I576A OVERCOME: 31/07/2020 1000 CICLOFOSFAMIDA MEDICINAL PRODUCT FOR HUMAN 17-038372-1 MG EXP DATE 05/04/2017 | 200.51 | KG | LKM PERU S.A. | LA******SA. | ARGENTINA | |
| 09-05-2019 | 3822009000 | Reactivos De Diagnostico O De Laboratorio Sobre Cualquier Soporte Y Reactivos De Diagnostico O De Laboratorio Preparados, Incluso Sobre Soporte, Excepto Los De Las Partidas 30.02 O 30.06 ESTANDAR CICLOFOSFAMIDA, S/M, S/M CAJA ESTANDARD S/C | REAGENTS DIAGNOSTIC OR LABORATORY REAGENTS ON A BACKING AND DIAGNOSTIC OR LABORATORY PREPARATIONS, EVEN ON A BACKING, OTHER THAN THOSE OF HEADING 3002 OR 3006 STANDARD CYCLOPHOSPHAMIDE, S / M S / M CASE STANDARD S / C | 0.2 | KG | GP PHARM S.A. | | ARGENTINA | |
| 21-05-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CYCLOPHOSPHAMIDE 1G, BAXTER ONCOLOGY GMBH, S/M PRINCIPIO ACTIVO: CICLOFOSFAMIDA PROTOCOLO: TX05-03 POLVO PARA SOLUCION INYECTABLE / INTRAVENOSA MUESTRAS SIN VALOR COMERCIAL | MEDICINAL PRODUCTS FOR HUMAN USE, FOR HIV CYCLOPHOSPHAMIDE TREATMENT ONCOLOGICO O 1G, BAXTER ONCOLOGY GMBH, S / M ACTIVE: CICLOFOSFAMIDA PROTOCOL: TX05-03 POWDER FOR INJECTION / INTRAVENOSA SAMPLES WITHOUT COMMERCIAL VALUE | 2.59 | KG | ICON CLINICAL RESEARCH PERU S.A. | AL******CES | GERMANY | |
| 11-06-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 1G CICLOFOSFAMIDA 1G / L:01954 / VTO: 05/2021 / EN CAJA DE CARTON X 1 VIAL S/M S/M | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 1G 1G / L: 01954 / VTO: 05/2021 / EN CARTON X 1 VIAL S / M S / M | 71.96 | KG | PERULAB SA | LA******.A. | ARGENTINA | |
| 17-06-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, LKM, S/M CODIGO 23011 , LOTE I946 VCE 31.03.2021 MEDICAMENTO PARA HUMANO CICLOFOSFAMIDA 1GR X 1 FA PE EXPEDIENTE 17-038372 DEL 04.05.2017 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, LKM, S / M CODE 23011, LOT I946 VCE 03.31.2021 FOR HUMAN CICLOFOSFAMIDA 1GR MEDICINAL X 1 FA PE 17-038372 RECORD OF 05.04.2017 | 195.48 | KG | LKM PERU S.A. | LA****** SA | ARGENTINA | |
| 24-06-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, LKM, S/M CODIGO 23011, CICLOSFAMIDA 1 GR X 1 FA_PE 1948A MEDICAMENTO PARA HUMANO CICLOFOSFAMIDA EXP. 17-038372-1 DE FECHA 04.05.2017 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, LKM, S / M CODE 23011, GR CYCLOSPHAMIDE 1 X 1 FA_PE 1948A FOR HUMAN CICLOFOSFAMIDA EXP MEDICINAL. 17-038372-1 DATED 04/05/2017 | 246.46 | KG | LKM PERU S.A. | LA******SA, | ARGENTINA | |
| 24-06-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA, LKM, S/M CODIGO 23011, CICLOSFAMIDA 1 GR X 1 FA_PE I578A MEDICAMENTO PARA HUMANO CICLOFOSFAMIDA EXP. 17-038372-1 DE FECHA 04.05.2017 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE, LKM, S / M CODE 23011, GR CYCLOSPHAMIDE 1 X 1 FA_PE I578A FOR HUMAN CICLOFOSFAMIDA EXP MEDICINAL. 17-038372-1 DATED 04/05/2017 | 224.21 | KG | LKM PERU S.A. | LA******SA, | ARGENTINA | |
| 01-07-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih MEDICAMENTO S/M S/M CYCLOPHOSPHAMIDE 1000 MG / CICLOFOSFAMIDA 1000 MG PARA EL TRATAMIENTO DEL CANCER DE MAMA TRIPLE NEGATIVO OPERABLE CAJA CONTENIENDO UN VIAL ESTUDIO CLINICO PROTOCOLO WO339391 RO 024-2106 1 VIAL CYCLOPHOSPHAMIDE 1000 MG LOTE: 7F123D, 1156854 VENC 06/2020 | MEDICINAL PRODUCTS FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O-HIV DRUG S / MS / M CYCLOPHOSPHAMIDE 1000 MG / CYCLOPHOSPHAMIDE 1000 MG FOR BREAST CANCER MANAGEMENT BOX CONTAINING TRIPLE NEGATIVE OPERABLE VIAL RO WO339391 PROTOCOL TRIAL 024-2106 1000 MG 1 VIAL CYCLOPHOSPHAMIDE LOT: 7F123D, 1156854 06/2020 VENC | 11 | KG | ROCHE FARMA (PERU) S.A. | F.****** AG | GERMANY | |
| 17-07-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CYCLOPHOSPHAMIDE INJECTION 1GM, S/M, S/M LOTE N? HEICA9001 FAB: 06.2019 VENCE: 05.2021 CICLOFOSFAMIDA 1G POLVO PARA SOLUCI?N INYECTABLE CYCLOPHOSPHAMIDE INJECTION USP 1 GM LEY N? 27450, LEY QUE EXONERA DE PAGO DE IGV Y DERECHOS ARANCELARIOS,A LOS MEDICAMENTOS | MEDICINAL PRODUCTS FOR HUMAN USE, FOR HIV CYCLOPHOSPHAMIDE TREATMENT ONCOLOGICO O INJECTION 1GM, S / M, S / M LOT N? HEICA9001 FAB: 06.2019 EXPIRES: 05.2021 CICLOFOSFAMIDA 1G POWDER FOR SOLUTION INJECTION USP CYCLOPHOSPHAMIDE N INYECTABLE 1 GM LAW N? 27450, ACT EXONERATING IGV PAYMENT AND CUSTOMS DUTIES, TO DRUGS | 1320 | KG | CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD | VE******LTD | INDIA | |
| 08-08-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 200MG, S/M, S/M CAJA X 1 VIAL MEDICAMENTO DE USO ONCOLOGICO POLVO PARA SOLUCION INYECTABLE, LOTE: 368A02, VENCE: 06/2021 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE 200MG, S / M S / M BOX X 1 VIAL MEDICINAL USE ONCOLOGICO POWDER FOR INJECTION, LOT: 368A02 OVERCOME: 06/2021 | 82.28 | KG | | ARGENTINA | ||
| 08-08-2019 | 3822009000 | Reactivos De Diagnostico O De Laboratorio Sobre Cualquier Soporte Y Reactivos De Diagnostico O De Laboratorio Preparados, Incluso Sobre Soporte, Excepto Los De Las Partidas 30.02 O 30.06 ESTANDAR CICLOFOSFAMIDA, S/M, S/M CAJA ESTANDARD LOTE: MP2149R1, VENCE: 12/2020 | DIAGNOSTIC REAGENTS OR LABORATORY BACKING AND REAGENTS DIAGNOSTIC OR LABORATORY PREPARATIONS, EVEN ON A BACKING, OTHER THAN THOSE OF HEADING 3002 OR 3006 ESTANDAR CYCLOPHOSPHAMIDE, S / M, S / M BOX STANDARD LOT: MP2149R1 OVERCOME: 12 / 2020 | 0.01 | KG | | ARGENTINA | ||
| 13-08-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 200MG, S/M, S/M CAJA X 1 VIAL MEDICAMENTO DE USO ONCOLOGICO POLVO PARA SOLUCION INYECTABLE, LOTE: 397A01, LOTE: 398A01 VENCE: 07/2021 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE 200MG, S / M S / M BOX X 1 VIAL MEDICINAL USE ONCOLOGICO POWDER FOR INJECTION, LOT: 397A01, LOT: 398A01 DUE: 07/2021 | 273.01 | KG | GP****** SA | ARGENTINA | ||
| 23-08-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 200MG, S/M, S/M CAJA X 1 VIAL MEDICAMENTO DE USO ONCOLOGICO POLVO PARA SOLUCION INYECTABLE, LOTE: 398A01, VENCE: 07/2021 | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE 200MG, S / M S / M BOX X 1 VIAL MEDICINAL USE ONCOLOGICO POWDER FOR INJECTION, LOT: 398A01 OVERCOME: 07/2021 | 180.18 | KG | GP****** SA | ARGENTINA | ||
| 26-08-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CYCLOPHOSPHAMIDE 1G, BAXTER ONCOLOGY GMBH, S/M PRINCIPIO ACTIVO: CICLOFOSFAMIDA PROTOCOLO: TX05-03 POLVO PARA SOLUCION INYECTABLE / INTRAVENOSA 1G MUESTRAS SIN VALOR COMERCIAL | MEDICINAL PRODUCTS FOR HUMAN USE, FOR HIV CYCLOPHOSPHAMIDE TREATMENT ONCOLOGICO O 1G, BAXTER ONCOLOGY GMBH, S / M ACTIVE: CICLOFOSFAMIDA PROTOCOL: TX05-03 POWDER FOR INJECTION / INTRAVENOSA 1G SAMPLES WITHOUT COMMERCIAL VALUE | 2.1 | KG | AL******CES | GERMANY | ||
| 18-12-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CYCLOPHOSPHAMIDE 1G, BAXTER ONCOLOGY GMBH, S/M PRINCIPIO ACTIVO: CICLOFOSFAMIDA PROTOCOLO: TX05-03 POLVO PARA SOLUCION INYECTABLE / INTRAVENOSA MUESTRAS SIN VALOR COMERCIAL | MEDICINAL PRODUCTS FOR HUMAN USE, FOR HIV CYCLOPHOSPHAMIDE TREATMENT ONCOLOGICO O 1G, BAXTER ONCOLOGY GMBH, S / M ACTIVE: CICLOFOSFAMIDA PROTOCOL: TX05-03 POWDER FOR INJECTION / INTRAVENOSA SAMPLES WITHOUT COMMERCIAL VALUE | 5.5 | KG | ICON CLINICAL RESEARCH PERU S.A. | AL******ES, | GERMANY | |
| 23-12-2019 | 3004902400 | Medicamentos Para Uso Humano, Para Tratamiento Oncologico O Vih CICLOFOSFAMIDA 200MG, S/M, S/M CAJA X 1 VIAL MEDICAMENTO DE USO ONCOLOGICO POLVO PARA SOLUCION INYECTABLE, LOTE: 455A01, VENCE: 11/2021. LOTE: 450A01 VENCE: 10/2021 CICLOFOSFAMIDA | MEDICINES FOR HUMAN USE, FOR TREATMENT ONCOLOGICO O HIV CYCLOPHOSPHAMIDE 200MG, S / M S / M BOX X 1 VIAL MEDICINAL USE ONCOLOGICO POWDER FOR INJECTION, LOT: 455A01 OVERCOME: 11/2021. LOT: 450A01 EXPIRES: 10/2021 CICLOFOSFAMIDA | 170.75 | KG | GP PHARM S.A. | G ****** SA | ARGENTINA |
Loading ....